Filed before 2025Filed 13 November 2017
Keros Therapeutics, Inc. has sold $11M so far
Keros Therapeutics, Inc., a biotech company based in Lexington, MA, has sold $11M so far in its equity round, according to a filing dated 13 November 2017.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 13 November 2017
- First filed
- 29 April 2016
- Round
- Equity round (amended filing)
- Amount sold
- $11M
- Offering size
- $11M
- Investors so far
- 7
- Based in
- Lexington, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 69% of the 1,645 tracked raises with an amount filed in 2017, and than 51% of the 152 in biotech.
Keros Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 12 Mar 2020 | New filing | $56M | Another raise |
| 21 Nov 2018 | New filing | $11.5M | Another raise |
| 13 Nov 2017 | Amended filing | $11M | This raise |
| 18 Aug 2016 | Amended filing | $3.67M | This raise |
| 29 Apr 2016 | New filing | $3.33M | This raise |
More with Partners Innovation on the board
- Claris Biotherapeutics, Inc.$55.7M
- CodaMetrix Inc.$11.6M
- Mediar Therapeutics, Inc.$85M
- SeQure Dx Inc.$2.18M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.